Premium
Cystic fibrosis drug approved for patients aged 6‐11 years worked well in clinical practice
Author(s) -
Loukou Ioanna,
Petrocheilou Argyri,
Moustaki Maria,
Katsagoni Christi.,
Douros Konstantinos
Publication year - 2021
Publication title -
acta paediatrica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.772
H-Index - 115
eISSN - 1651-2227
pISSN - 0803-5253
DOI - 10.1111/apa.15519
Subject(s) - medicine , cystic fibrosis , advisory committee , drug , conflict of interest , new drug application , family medicine , pharmacology , management , law , political science , economics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom